Clinical Research Directory
Browse clinical research sites, groups, and studies.
Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients
Sponsor: Al-Nahrain University
Summary
This study aims to evaluate whether the combination of Albumin and Furosemide can reduce the risk of Ovarian Hyperstimulation Syndrome in women undergoing intracytoplasmic sperm injection (ICSI) who are at high risk of developing this condition. Ovarian hyperstimulation syndrome is a potential complication of ovarian stimulation during assisted reproductive techniques, which can lead to symptoms such as abdominal swelling, fluid accumulation, and, in severe cases, hospitalization. Preventing this condition is important to improve patient safety and treatment outcomes. In this randomized controlled study, eligible women undergoing ICSI were assigned to receive either the combination of albumin and furosemide or standard care. The study compared the occurrence and severity of OHSS between the two groups. The results of this study may help identify an effective strategy to prevent OHSS and improve the safety of assisted reproductive treatments.
Official title: Effect of Albumin and Furosemide Combination for Prevention of Severe Ovarian Hyperstimulation Syndrome in Hyper-Responders Undergoing Intracytoplasmic Sperm Injection Cycles: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2019-04-29
Completion Date
2024-04-01
Last Updated
2026-05-06
Healthy Volunteers
No
Interventions
Albumin (Human) 20%
Intravenous human albumin 20% (100 mL) administered immediately after oocyte retrieval.
Furosemide
Intravenous furosemide 20 mg administered after oocyte retrieval.
Standard luteal phase support
Routine luteal phase support according to institutional protocol.
Locations (1)
High Institute for Infertility Diagnosis and ART
Baghdad, Baghdad Governorate, Iraq